Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer

To explore the mechanisms of radiotherapy resistance and search for prognostic biomarkers for prostate cancer.
Source: BMC Urology - Category: Urology & Nephrology Authors: Tags: Research Source Type: research